Company intelligence / Profile preview

Nichimo Biotics

Tokyo, Tokyo, Japan
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

Nichimo Biotics is a Japanese biotechnology company specializing in the development and manufacture of functional food ingredients and dietary supplements derived from fermented natural sources. A subsidiary of Nichimo Co., Ltd., the company leverages proprietary fermentation technologies, particularly using Aspergillus oryzae (Koji), to produce bioactive compounds like AglyMax and ImunoBran. AglyMax is a soy isoflavone aglycone designed for superior absorption, primarily targeting women's health and bone density. ImunoBran, also known as MGN-3, is a modified rice bran arabinoxylan used globally for immune system modulation and as a complementary therapy in oncology. The company maintains a strong focus on evidence-based research, collaborating with universities to validate the efficacy and safety of its products. Nichimo Biotics serves the global market, providing high-quality ingredients to the pharmaceutical, nutraceutical, and functional food industries.

Therapeutic areas
OncologyEndocrinologyImmunologyWomen's Health
Modalities
Small moleculeBiologicPeptides
Industry
Food & Nutrition
02

Partnerships

Daiwa Pharmaceutical

Beyond the preview

Go deeper on Nichimo Biotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nichimo Biotics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call